Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Bhargava Kandala, MS, PhD

Director
Merck & Co Inc

Bhargava Kandala, Ph.D., is currently a Director in the Quantitative Pharmacology, Pharmacometrics group at Merck. He is passionate about driving model informed drug development (MIDD) approaches to develop novel drug and vaccines. Dr. Kandala received his M.S. in Statistics, and Ph.D. in Pharmaceutical Science from University of Florida in 2012 and 2014, respectively. Since joining Merck in 2014, he has successfully applied quantitative approaches in developing safe and efficacious drugs and vaccines across therapeutic areas comprising Infectious diseases, Vaccines, Diabetes, Women’s health, and Oncology. He has contributed to the clinical pharmacology and pharmacometrics field with publications in Lancet EbioMedicine, Clinical Pharmacology and Therapeutics, and Antimicrobial Agents and Chemotherapy.
Dr. Kandala is a recipient of the 2023 University of Florida 40 Under 40 award given to Outstanding Young Alumni. He is an active member of professional societies such as the International Society of Pharmacometrics (ISoP) and the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Dr. Kandala also enjoys mentoring students in data science and MIDD; and holds an adjunct faculty appointment within the Department of Pharmaceutics at UF College of Pharmacy.

Disclosure information not submitted.

Presentation(s):